Mallinckrodt To Present At BMO Prescriptions For Success Healthcare Conference

[anonymous]

STAINES-UPON-THAMES, United Kingdom, Nov. 12, 2018 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Dec. 12, 2018, at the BMO Prescriptions for Success Healthcare Conference at the Mandarin Oriental, 80 Columbus Circle, New York.

Steven Romano, M.D., Executive Vice President and Chief Scientific Officer, and Hugh O'Neill, Executive Vice President and Chief Commercial Officer, will represent the company in a fireside chat at 8 a.m. Eastern.

 

[anonymous]

STAINES-UPON-THAMES, United Kingdom, Nov. 12, 2018 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Dec. 12, 2018, at the BMO Prescriptions for Success Healthcare Conference at the Mandarin Oriental, 80 Columbus Circle, New York.

Steven Romano, M.D., Executive Vice President and Chief Scientific Officer, and Hugh O'Neill, Executive Vice President and Chief Commercial Officer, will represent the company in a fireside chat at 8 a.m. Eastern.

Hugh thanks for stopping in at the café for a espresso, your HUGE RED font is a continued giveaway that you continue to monitor this board.
The only thing more laughable is this quote MALLINCKRODT A LEADING GLOBAL SPECIALTY PHARMACEUTICAL COMPANY; OMG so wrong on a number of fronts with that statement